1
|
Lopez-Mendez TB, Santos-Vizcaino E, Pedraz JL, Orive G, Hernandez RM. Cell microencapsulation technologies for sustained drug delivery: Latest advances in efficacy and biosafety. J Control Release 2021; 335:619-636. [PMID: 34116135 DOI: 10.1016/j.jconrel.2021.06.006] [Citation(s) in RCA: 27] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2020] [Revised: 06/04/2021] [Accepted: 06/06/2021] [Indexed: 10/21/2022]
Abstract
The development of cell microencapsulation systems began several decades ago. However, today few systems have been tested in clinical trials. For this reason, in the last years, researchers have directed efforts towards trying to solve some of the key aspects that still limit efficacy and biosafety, the two major criteria that must be satisfied to reach the clinical practice. Regarding the efficacy, which is closely related to biocompatibility, substantial improvements have been made, such as the purification or chemical modification of the alginates that normally form the microspheres. Each of the components that make up the microcapsules has been carefully selected to avoid toxicities that can damage the encapsulated cells or generate an immune response leading to pericapsular fibrosis. As for the biosafety, researchers have developed biological circuits capable of actively responding to the needs of the patients to precisely and accurately release the demanded drug dose. Furthermore, the structure of the devices has been subject of study to adequately protect the encapsulated cells and prevent their spread in the body. The objective of this review is to describe the latest advances made by scientist to improve the efficacy and biosafety of cell microencapsulation systems for sustained drug delivery, also highlighting those points that still need to be optimized.
Collapse
Affiliation(s)
- Tania B Lopez-Mendez
- NanoBioCel Research Group, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad, 7, 01006 Vitoria-Gasteiz, Spain; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, C/Monforte de Lemos 3-5, 28029 Madrid, Spain
| | - Edorta Santos-Vizcaino
- NanoBioCel Research Group, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad, 7, 01006 Vitoria-Gasteiz, Spain; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, C/Monforte de Lemos 3-5, 28029 Madrid, Spain; Bioaraba, NanoBioCel Research Group, Vitoria-Gasteiz, Spain
| | - Jose Luis Pedraz
- NanoBioCel Research Group, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad, 7, 01006 Vitoria-Gasteiz, Spain; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, C/Monforte de Lemos 3-5, 28029 Madrid, Spain; Bioaraba, NanoBioCel Research Group, Vitoria-Gasteiz, Spain
| | - Gorka Orive
- NanoBioCel Research Group, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad, 7, 01006 Vitoria-Gasteiz, Spain; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, C/Monforte de Lemos 3-5, 28029 Madrid, Spain; Bioaraba, NanoBioCel Research Group, Vitoria-Gasteiz, Spain; University Institute for Regenerative Medicine and Oral Implantology - UIRMI (UPV/EHU-Fundación Eduardo Anitua), BTI Biotechnology Institute, Vitoria-Gasteiz, Spain; Singapore Eye Research Institute, The Academia, 20 College Road, Discovery Tower, Singapore.
| | - Rosa Maria Hernandez
- NanoBioCel Research Group, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad, 7, 01006 Vitoria-Gasteiz, Spain; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, C/Monforte de Lemos 3-5, 28029 Madrid, Spain; Bioaraba, NanoBioCel Research Group, Vitoria-Gasteiz, Spain.
| |
Collapse
|
2
|
Abstract
Recent developments within micro-computed tomography (μCT) imaging have combined to extend our capacity to image tissue in three (3D) and four (4D) dimensions at micron and sub-micron spatial resolutions, opening the way for virtual histology, live cell imaging, subcellular imaging and correlative microscopy. Pivotal to this has been the development of methods to extend the contrast achievable for soft tissue. Herein, we review the new capabilities within the field of life sciences imaging, and consider how future developments in this field could further benefit the life sciences community.
Collapse
Affiliation(s)
- Shelley D Rawson
- The Henry Royce Institute and School of Materials, The University of Manchester, Manchester, M13 9PL, UK
| | - Jekaterina Maksimcuka
- The Henry Royce Institute and School of Materials, The University of Manchester, Manchester, M13 9PL, UK
| | - Philip J Withers
- The Henry Royce Institute and School of Materials, The University of Manchester, Manchester, M13 9PL, UK
| | - Sarah H Cartmell
- The Henry Royce Institute and School of Materials, The University of Manchester, Manchester, M13 9PL, UK.
| |
Collapse
|
3
|
Bouché M, Hsu JC, Dong YC, Kim J, Taing K, Cormode DP. Recent Advances in Molecular Imaging with Gold Nanoparticles. Bioconjug Chem 2020; 31:303-314. [PMID: 31682405 PMCID: PMC7032998 DOI: 10.1021/acs.bioconjchem.9b00669] [Citation(s) in RCA: 75] [Impact Index Per Article: 18.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Gold nanoparticles (AuNP) have been extensively developed as contrast agents, theranostic platforms, and probes for molecular imaging. This popularity has yielded a large number of AuNP designs that vary in size, shape, surface functionalization, and assembly, to match very closely the requirements for various imaging applications. Hence, AuNP based probes for molecular imaging allow the use of computed tomography (CT), fluorescence, and other forms of optical imaging, photoacoustic imaging (PAI), and magnetic resonance imaging (MRI), and other newer techniques. The unique physicochemical properties, biocompatibility, and highly developed chemistry of AuNP have facilitated breakthroughs in molecular imaging that allow the detection and imaging of physiological processes with high sensitivity and spatial resolution. In this Review, we summarize the recent advances in molecular imaging achieved using novel AuNP structures, cell tracking using AuNP, targeted AuNP for cancer imaging, and activatable AuNP probes. Finally, the perspectives and current limitations for the clinical translation of AuNP based probes are discussed.
Collapse
Affiliation(s)
- Mathilde Bouché
- Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States
| | - Jessica C. Hsu
- Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States
- Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States
| | - Yuxi C. Dong
- Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States
- Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States
| | - Johoon Kim
- Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States
- Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States
| | - Kimberly Taing
- Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States
| | - David P. Cormode
- Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States
- Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States
| |
Collapse
|
4
|
Yadav P, Singh SP, Rengan AK, Shanavas A, Srivastava R. Gold laced bio-macromolecules for theranostic application. Int J Biol Macromol 2018; 110:39-53. [DOI: 10.1016/j.ijbiomac.2017.10.124] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2017] [Revised: 09/26/2017] [Accepted: 10/18/2017] [Indexed: 02/07/2023]
|
5
|
Pedone D, Moglianetti M, De Luca E, Bardi G, Pompa PP. Platinum nanoparticles in nanobiomedicine. Chem Soc Rev 2018; 46:4951-4975. [PMID: 28696452 DOI: 10.1039/c7cs00152e] [Citation(s) in RCA: 227] [Impact Index Per Article: 37.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Oxidative stress-dependent inflammatory diseases represent a major concern for the population's health worldwide. Biocompatible nanomaterials with enzymatic properties could play a crucial role in the treatment of such pathologies. In this respect, platinum nanoparticles (PtNPs) are promising candidates, showing remarkable catalytic activity, able to reduce the intracellular reactive oxygen species (ROS) levels and impair the downstream pathways leading to inflammation. This review reports a critical overview of the growing evidence revealing the anti-inflammatory ability of PtNPs and their potential applications in nanomedicine. It provides a detailed description of the wide variety of synthetic methods recently developed, with particular attention to the aspects influencing biocompatibility. Special attention has been paid to the studies describing the toxicological profile of PtNPs with an attempt to draw critical conclusions. The emerging picture suggests that the material per se is not causing cytotoxicity, while other physicochemical features related to the synthesis and surface functionalization may play a crucial role in determining the observed impairment of cellular functions. The enzymatic activity of PtNPs is also summarized, analyzing their action against ROS produced by pathological conditions within the cells. In particular, we extensively discuss the potential of these properties in nanomedicine to down-regulate inflammatory pathways or to be employed as diagnostic tools with colorimetric readout. A brief overview of other biomedical applications of nanoplatinum is also presented.
Collapse
Affiliation(s)
- Deborah Pedone
- Istituto Italiano di Tecnologia, Nanobiointeractions & Nanodiagnostics, Via Morego 30, 16163 Genova, Italy.
| | | | | | | | | |
Collapse
|
6
|
Lv L, Schlangen E, Xing F. Self-Sealing Cementitious Materials by Using Water-Swelling Rubber Particles. MATERIALS 2017; 10:ma10080979. [PMID: 28829384 PMCID: PMC5578345 DOI: 10.3390/ma10080979] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/25/2017] [Revised: 08/15/2017] [Accepted: 08/18/2017] [Indexed: 11/18/2022]
Abstract
Water ingress into cracked concrete structures is a serious problem, as it can cause leakage and reinforcement corrosion and thus reduce functionality and safety of the structures. In this study, the application of water-swelling rubber particles for providing the cracked concrete a self-sealing function was developed. The feasibility of applying water-swelling rubber particles and the influence of incorporating water-swelling rubber particles on the mechanical properties of concrete was investigated. The self-sealing efficiency of water-swelling rubber particles with different content and particle size was quantified through a permeability test. The sealing effect of the water swelling rubber particles was monitored by X-ray computed tomography. The experimental results show that, by using 6% of these water swelling rubber particles as a replacement of aggregates in concrete, up to 64% and 61% decrease of water permeability was realized for 0.7 mm and 1.0 mm cracks. Furthermore, when the concrete cracks, the water swelling rubber particles can act as a crack bridging filler, preventing the crack from fully separating the specimens in two pieces.
Collapse
Affiliation(s)
- Leyang Lv
- Micromechanics Laboratory (MICROLAB), Faculty of Civil Engineering and Geosciences, Delft University of Technology, Stevinweg 1, 2628 CN Delft, The Netherlands.
- Guangdong Province Key Laboratory of Durability for Marine Civil Engineering, School of Civil Engineering, Shenzhen University, Shenzhen 518060, China.
| | - Erik Schlangen
- Micromechanics Laboratory (MICROLAB), Faculty of Civil Engineering and Geosciences, Delft University of Technology, Stevinweg 1, 2628 CN Delft, The Netherlands.
| | - Feng Xing
- Guangdong Province Key Laboratory of Durability for Marine Civil Engineering, School of Civil Engineering, Shenzhen University, Shenzhen 518060, China.
| |
Collapse
|
7
|
Abstract
Transplantation of pancreatic islets encapsulated within immuno-protective microcapsules is a strategy that has the potential to overcome graft rejection without the need for toxic immunosuppressive medication. However, despite promising preclinical studies, clinical trials using encapsulated islets have lacked long-term efficacy, and although generally considered clinically safe, have not been encouraging overall. One of the major factors limiting the long-term function of encapsulated islets is the host's immunological reaction to the transplanted graft which is often manifested as pericapsular fibrotic overgrowth (PFO). PFO forms a barrier on the capsule surface that prevents the ingress of oxygen and nutrients leading to islet cell starvation, hypoxia and death. The mechanism of PFO formation is still not elucidated fully and studies using a pig model have tried to understand the host immune response to empty alginate microcapsules. In this review, the varied strategies to overcome or reduce PFO are discussed, including alginate purification, altering microcapsule geometry, modifying alginate chemical composition, co-encapsulation with immunomodulatory cells, administration of pharmacological agents, and alternative transplantation sites. Nanoencapsulation technologies, such as conformal and layer-by-layer coating technologies, as well as nanofiber, thin-film nanoporous devices, and silicone based NanoGland devices are also addressed. Finally, this review outlines recent progress in imaging technologies to track encapsulated cells, as well as promising perspectives concerning the production of insulin-producing cells from stem cells for encapsulation.
Collapse
Affiliation(s)
- Vijayaganapathy Vaithilingam
- Materials Science and Engineering, Commonwealth Scientific and Industrial Research Organization (CSIRO), North Ryde, New South Wales, Australia
| | - Sumeet Bal
- Materials Science and Engineering, Commonwealth Scientific and Industrial Research Organization (CSIRO), North Ryde, New South Wales, Australia
| | - Bernard E Tuch
- School of Medical Sciences, The University of Sydney, Sydney, New South Wales, Australia
| |
Collapse
|
8
|
Meir R, Popovtzer R. Cell tracking using gold nanoparticles and computed tomography imaging. WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY 2017; 10. [PMID: 28544497 DOI: 10.1002/wnan.1480] [Citation(s) in RCA: 48] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/07/2017] [Revised: 04/04/2017] [Accepted: 04/18/2017] [Indexed: 12/28/2022]
Abstract
Cell-based therapies utilize transplantation of living cells with therapeutic traits to alleviate numerous diseases and disorders. The use of such biological agents is an attractive alternative for diseases that existing medicine cannot effectively treat. Although very promising, translating cell therapy to the clinic has proven to be challenging, due to inconsistent results in preclinical and clinical studies. To examine the underlying cause for these inconsistencies, it is crucial to noninvasively monitor the accuracy of cell injection, and cell survival and migration patterns. The combination of classical imaging techniques with cellular contrast agents-mainly nanotechnological-based-has enabled significant developments in cell-tracking methodologies. One novel methodology, based on computed tomography (CT) as an imaging modality and gold nanoparticles (AuNPs) as contrast agents, has recently gained interest for its clinical applicability and cost-effectiveness. Studies have shown that AuNPs can be used to efficiently label a variety of cell types, including stem cells and immune cells, without damaging their therapeutic efficacy. Successful in vivo experiments have demonstrated noninvasive, quantitative and longitudinal cell tracking with high sensitivity. This concept has the potential to be used not only as a research tool, but in clinical settings as well. WIREs Nanomed Nanobiotechnol 2018, 10:e1480. doi: 10.1002/wnan.1480 This article is categorized under: Diagnostic Tools > In Vivo Nanodiagnostics and Imaging.
Collapse
Affiliation(s)
- Rinat Meir
- Faculty of Engineering and the Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan, Israel
| | - Rachela Popovtzer
- Faculty of Engineering and the Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan, Israel
| |
Collapse
|
9
|
Kim J, Chhour P, Hsu J, Litt HI, Ferrari VA, Popovtzer R, Cormode DP. Use of Nanoparticle Contrast Agents for Cell Tracking with Computed Tomography. Bioconjug Chem 2017; 28:1581-1597. [PMID: 28485976 PMCID: PMC5481820 DOI: 10.1021/acs.bioconjchem.7b00194] [Citation(s) in RCA: 78] [Impact Index Per Article: 11.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
![]()
Efforts
to develop novel cell-based therapies originated with the
first bone marrow transplant on a leukemia patient in 1956. Preclinical
and clinical examples of cell-based treatment strategies have shown
promising results across many disciplines in medicine, with recent
advances in immune cell therapies for cancer producing remarkable
response rates, even in patients with multiple treatment failures.
However, cell-based therapies suffer from inconsistent outcomes, motivating
the search for tools that allow monitoring of cell delivery and behavior
in vivo. Noninvasive cell imaging techniques, also known as cell tracking,
have been developed to address this issue. These tools can allow real-time,
quantitative, and long-term monitoring of transplanted cells in the
recipient, providing insight on cell migration, distribution, viability,
differentiation, and fate, all of which play crucial roles in treatment
efficacy. Understanding these parameters allows the optimization of
cell choice, delivery route, and dosage for therapy and advances cell-based
therapy for specific clinical uses. To date, most cell tracking work
has centered on imaging modalities such as MRI, radionuclide imaging,
and optical imaging. However, X-ray computed tomography (CT) is an
emerging method for cell tracking that has several strengths such
as high spatial and temporal resolution, and excellent quantitative
capabilities. The advantages of CT for cell tracking are enhanced
by its wide availability and cost effectiveness, allowing CT to become
one of the most popular clinical imaging modalities and a key asset
in disease diagnosis. In this review, we will discuss recent advances
in cell tracking methods using X-ray CT in various applications, in
addition to predictions on how the field will progress.
Collapse
Affiliation(s)
| | | | | | | | | | - Rachela Popovtzer
- Department of Engineering, Bar-Ilan University , Ramat Gan, 5290002, Israel
| | | |
Collapse
|
10
|
Micromechanical Properties of a New Polymeric Microcapsule for Self-Healing Cementitious Materials. MATERIALS 2016; 9:ma9121025. [PMID: 28774144 PMCID: PMC5457007 DOI: 10.3390/ma9121025] [Citation(s) in RCA: 60] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/08/2016] [Revised: 12/05/2016] [Accepted: 12/15/2016] [Indexed: 11/17/2022]
Abstract
Self-healing cementitious materials containing a microencapsulated healing agent are appealing due to their great application potential in improving the serviceability and durability of concrete structures. In this study, poly(phenol–formaldehyde) (PF) microcapsules that aim to provide a self-healing function for cementitious materials were prepared by an in situ polymerization reaction. Size gradation of the synthesized microcapsules was achieved through a series of sieving processes. The shell thickness and the diameter of single microcapsules was accurately measured under environmental scanning electron microscopy (ESEM). The relationship between the physical properties of the synthesized microcapsules and their micromechanical properties were investigated using nanoindentation. The results of the mechanical tests show that, with the increase of the mean size of microcapsules and the decrease of shell thickness, the mechanical force required to trigger the self-healing function of microcapsules increased correspondingly from 68.5 ± 41.6 mN to 198.5 ± 31.6 mN, featuring a multi-sensitive trigger function. Finally, the rupture behavior and crack surface of cement paste with embedded microcapsules were observed and analyzed using X-ray computed tomography (XCT). The synthesized PF microcapsules may find potential application in self-healing cementitious materials.
Collapse
|
11
|
Maiorano G, Mele E, Frassanito MC, Restini E, Athanassiou A, Pompa PP. Ultra-efficient, widely tunable gold nanoparticle-based fiducial markers for X-ray imaging. NANOSCALE 2016; 8:18921-18927. [PMID: 27812579 DOI: 10.1039/c6nr07021c] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
We show the development of a new class of highly efficient, biocompatible fiducial markers for X-ray imaging and radiosurgery, based on polymer shells encapsulating engineered gold nanoparticle (AuNP) suspensions. Our smart fabrication strategy enables wide tunability of the fiducial size, shape, and X-ray attenuation performance, up to record values >20 000 Hounsfield units (HU), i.e. comparable to or even higher than bulk gold. We show that the NP fiducials allow for superior imaging both in vitro and in vivo (yet requiring 2 orders of magnitude less material), with strong stability over time and the absence of classical "streak artifacts" of standard bulk fiducials. NP fiducials were probed in vivo, showing exceptional contrast efficiency, even after 2 weeks post-implant in mice.
Collapse
Affiliation(s)
- G Maiorano
- Nanobiointeractions & Nanodiagnostics, Istituto Italiano di Tecnologia (IIT), Via Morego 30, 16163, Genoa, Italy.
| | | | | | | | | | | |
Collapse
|
12
|
Basuki JS, Qie F, Mulet X, Suryadinata R, Vashi AV, Peng YY, Li L, Hao X, Tan T, Hughes TC. Photo-Modulated Therapeutic Protein Release from a Hydrogel Depot Using Visible Light. Angew Chem Int Ed Engl 2016. [DOI: 10.1002/ange.201610618] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Affiliation(s)
- Johan S. Basuki
- CSIRO Manufacturing; Bayview Avenue Clayton Victoria Australia
| | - Fengxiang Qie
- Beijing Key Lab of Bioprocess; Beijing University of Chemical Technology; Beijing P.R. China
| | - Xavier Mulet
- CSIRO Manufacturing; Bayview Avenue Clayton Victoria Australia
| | | | - Aditya V. Vashi
- CSIRO Manufacturing; Bayview Avenue Clayton Victoria Australia
| | - Yong Y. Peng
- CSIRO Manufacturing; Bayview Avenue Clayton Victoria Australia
| | - Lingli Li
- School of Ophthalmology & Optometry and Eye Hospital; Wenzhou Medical University; Wenzhou P.R. China
| | - Xiaojuan Hao
- CSIRO Manufacturing; Bayview Avenue Clayton Victoria Australia
| | - Tianwei Tan
- Beijing Key Lab of Bioprocess; Beijing University of Chemical Technology; Beijing P.R. China
| | | |
Collapse
|
13
|
Basuki JS, Qie F, Mulet X, Suryadinata R, Vashi AV, Peng YY, Li L, Hao X, Tan T, Hughes TC. Photo-Modulated Therapeutic Protein Release from a Hydrogel Depot Using Visible Light. Angew Chem Int Ed Engl 2016; 56:966-971. [PMID: 27918129 DOI: 10.1002/anie.201610618] [Citation(s) in RCA: 44] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2016] [Indexed: 12/13/2022]
Abstract
The use of biomacromolecular therapeutics has revolutionized disease treatment, but frequent injections are required owing to their short half-life in vivo. Thus there is a need for a drug delivery system that acts as a reservoir and releases the drug remotely "on demand". Here we demonstrate a simple light-triggered local drug delivery system through photo-thermal interactions of polymer-coated gold nanoparticles (AuNPs) inside an agarose hydrogel as therapeutic depot. Localized temperature increase induced by the visible light exposure caused reversible softening of the hydrogel matrix to release the pre-loaded therapeutics. The release profile can be adjusted by AuNPs and agarose concentrations, light intensity and exposure time. Importantly, the biological activity of the released bevacizumab was highly retained. In this study we demonstrate the potential application of this facile AuNPs/hydrogel system for ocular therapeutics delivery through its versatility to release multiple biologics, compatibility to ocular cells and spatiotemporal control using visible light.
Collapse
Affiliation(s)
- Johan S Basuki
- CSIRO Manufacturing, Bayview Avenue, Clayton, Victoria, Australia
| | - Fengxiang Qie
- Beijing Key Lab of Bioprocess, Beijing University of Chemical Technology, Beijing, P.R. China
| | - Xavier Mulet
- CSIRO Manufacturing, Bayview Avenue, Clayton, Victoria, Australia
| | | | - Aditya V Vashi
- CSIRO Manufacturing, Bayview Avenue, Clayton, Victoria, Australia
| | - Yong Y Peng
- CSIRO Manufacturing, Bayview Avenue, Clayton, Victoria, Australia
| | - Lingli Li
- School of Ophthalmology & Optometry and Eye Hospital, Wenzhou Medical University, Wenzhou, P.R. China
| | - Xiaojuan Hao
- CSIRO Manufacturing, Bayview Avenue, Clayton, Victoria, Australia
| | - Tianwei Tan
- Beijing Key Lab of Bioprocess, Beijing University of Chemical Technology, Beijing, P.R. China
| | - Timothy C Hughes
- CSIRO Manufacturing, Bayview Avenue, Clayton, Victoria, Australia
| |
Collapse
|
14
|
Cell encapsulation: technical and clinical advances. Trends Pharmacol Sci 2015; 36:537-46. [DOI: 10.1016/j.tips.2015.05.003] [Citation(s) in RCA: 123] [Impact Index Per Article: 13.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2015] [Revised: 05/13/2015] [Accepted: 05/14/2015] [Indexed: 01/18/2023]
|
15
|
Qie F, Astolfo A, Wickramaratna M, Behe M, Evans MDM, Hughes TC, Hao X, Tan T. Self-assembled gold coating enhances X-ray imaging of alginate microcapsules. NANOSCALE 2015; 7:2480-2488. [PMID: 25567482 DOI: 10.1039/c4nr06692h] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
Therapeutic biomolecules produced from cells encapsulated within alginate microcapsules (MCs) offer a potential treatment for a number of diseases. However the fate of such MCs once implanted into the body is difficult to establish. Labelling the MCs with medical imaging contrast agents may aid their detection and give researchers the ability to track them over time thus aiding the development of such cellular therapies. Here we report the preparation of MCs with a self-assembled gold nanoparticle (AuNPs) coating which results in distinctive contrast and enables them to be readily identified using a conventional small animal X-ray micro-CT scanner. Cationic Reversible Addition-Fragmentation chain Transfer (RAFT) homopolymer modified AuNPs (PAuNPs) were coated onto the surface of negatively charged alginate MCs resulting in hybrids which possessed low cytotoxicity and high mechanical stability in vitro. As a result of their high localized Au concentration, the hybrid MCs exhibited a distinctive bright circular ring even with a low X-ray dose and rapid scanning in post-mortem imaging experiments facilitating their positive identification and potentially enabling them to be used for in vivo tracking experiments over multiple time-points.
Collapse
Affiliation(s)
- Fengxiang Qie
- Beijing Key Lab of Bioprocess, Beijing University of Chemical Technology, Beijing, PR China.
| | | | | | | | | | | | | | | |
Collapse
|